Visium Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $219K | Sell |
|
|||||
|
2016
Q1 | $73.7M | Sell |
|
|||||
|
2015
Q4 | $125M | Buy |
|
|||||
|
2015
Q3 | $87.5M | Buy |
|
|||||
|
2015
Q2 | $95.9M | Sell |
|
|||||
|
2015
Q1 | $120M | Buy |
|
|||||
|
2014
Q4 | $55M | Buy |
|
|||||
|
2014
Q3 | $28M | Buy |
|
|||||
|
2014
Q2 | $26.5M | Sell |
|
|||||
|
2014
Q1 | $32.2M | Sell |
|
|||||
|
2013
Q4 | $19.7M | Buy |
|
|||||
|
2013
Q3 | $20.5M | Sell |
|
|||||
|
2013
Q2 | $26.1M | Buy |
|